The court said US based Burger King Corporation has "miserably...
Category:
Eco/Invest/Demography
Latest
FSSAI launches project to address microplastic contamination in Indian food
In a recent report, the Food and Agriculture Organization (FAO)...
Indian biz need to align cyber security budgets with growth objectives, says Kaspersky
Adrian Hia, Managing Director, APAC, Kaspersky In India, malware...
WHO experts say Chinese jabs show ‘safety’, but data lacking
The UN health agency’s Strategic Advisory Group of Experts on Immunization (SAGE) said it had reviewed the data provided so far, and that both vaccines “demonstrated safety and good efficacy against symptomatic Covid-19 disease”.
However, it warned, “both vaccines lacked data in older age groups and in persons with co-morbidities,” meaning other medical conditions.
No Sputnik V approval yet, SEC asks Dr Reddy’s for more data on vax
The Hyderabad-based pharma major had applied for its emergency licensure on February 19. The Committee looked into Dr. Reddy’s application, on Thursday. Sputnik V has not received the emergency use authorisation yet, as the SEC has sought additional data, according to top sources.
EU drug watchdog reaffirms no particular clot risk factor linked to AstraZeneca vaccine
While repeating that the vaccine’s benefits outweigh risks, it cautioned that people should be aware of the “remote possibility” of rare blood clots occurring, and must seek immediate medical attention in case of symptoms.
Hong Kong is set to target first SPAC listing by end of year
One major issue in Hong Kong could become securing liability insurance for SPAC directors and officers against incorrect statements and negligence. Such insurance is already double the cost for many Chinese firms listed in the U.S. because of increased scrutiny and activism in recent years, said Sandra Lee, Asia chief executive at reinsurance broker BMS Group.
For the even smaller SPAC market it’s “almost impossible” to get D&O liability insurance, leaving the Chinese owners exposed to claims, Lee said
BioNTech owners in talks to invest in German cancer labs group
The billionaire Struengmann family behind Covid-19 vaccine maker BioNTech is in talks to take a stake in German diagnostics firm Munich Leukemia Laboratory (MLL) as it seeks to add investments in the healthcare sector, people close to the matter said.
“We are fundamentally interested in a deeper integration of therapy and diagnostics. That is why we are holding talks with Munich Leukemia Laboratory,” a spokesman for the Struengmann family holding Athos said.
Skyrocketing liability insurance rates for SPACs
. Coverage of about $10 million to indemnify a blank-check company’s directors and officers now costs more than $1 million on average, according to a lawyer who works on SPAC deals. That’s up from $250,000 to $300,000 a year ago.
India’s on its way to become the world’s pharmaceutical hub
At present, India is the largest provider of generic drugs globally. Indian pharma companies cater to over half of the global demand for various vaccines, along with 40 per cent of generic drugs demand in the US.
Notably, data from container logistics company Maersk showed that among the refrigerated cargo, pharmaceuticals export out of India rose steeply during 2020, with Q4 alone recording 47 per cent higher volumes as compared to the same period in 2019.
Rajasthan launches health insurance scheme for all claims it to be a first
The state began the registration for Chiranjeevi Health Insurance Scheme, announced by Chief Minister Ashok Gehlot in the state budget 2021-22.
“Rajasthan has become the first state in the country, where each family will get health insurance of Rs 5 lakh each year. People can get registered and be assured of cashless treatment,” Gehlot claimed in a tweet
COVID-19: India records 72,330 new cases, highest single day rise
Registering a steady increase for the 22nd day in row, the active cases have increased to 5,84,055 comprising 4.78 per cent of the total infections, while the recovery rate has further dropped to 93.89 per cent, the data stated.
No deaths reported, reduced severity: RML director on people contracting Covid after second vaccine dose
“So this is the kind of benefit which this vaccine is giving. We have not seen that those who got vaccinated and contracted the disease died. It doesn’t take a severe form in those who got vaccinated. We should grab the earliest opportunity to get vaccinated,” Director and Medical Superintendent, RML Hospital Dr Rana Anil Kumar Singh said .